Published in Am J Transplant on April 04, 2012
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) (APOLLO) | NCT03615235
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant (2015) 2.62
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation (2016) 1.68
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines. J Am Soc Nephrol (2014) 1.42
Plasma apolipoprotein L1 levels do not correlate with CKD. J Am Soc Nephrol (2013) 1.15
APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes. J Am Soc Nephrol (2016) 1.11
APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death. J Am Soc Nephrol (2016) 1.09
Host APOL1 genotype is independently associated with proteinuria in HIV infection. Kidney Int (2013) 0.98
APOL1 Kidney Disease Risk Variants: An Evolving Landscape. Semin Nephrol (2015) 0.97
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects. J Am Soc Nephrol (2015) 0.96
Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder. Curr Opin Nephrol Hypertens (2013) 0.95
Characterization of circulating APOL1 protein complexes in African Americans. J Lipid Res (2015) 0.92
Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing. Kidney Int (2014) 0.89
Should kidney donors be genotyped for APOL1 risk alleles? Kidney Int (2015) 0.88
Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort. J Am Soc Nephrol (2016) 0.87
APOL1 toxin, innate immunity, and kidney injury. Kidney Int (2015) 0.86
The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status. Clin Infect Dis (2014) 0.84
APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease. J Am Soc Nephrol (2016) 0.84
Defining nephrotic syndrome from an integrative genomics perspective. Pediatr Nephrol (2014) 0.83
Hypertension-attributed nephropathy: what's in a name? Nat Rev Nephrol (2015) 0.82
Apolipoprotein L1 and Kidney Disease in African Americans. Trends Endocrinol Metab (2016) 0.82
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume. Kidney Int (2016) 0.81
Assessment and management of hypertension in transplant patients. J Am Soc Nephrol (2015) 0.81
Hypertension and chronic kidney disease: controversies in pathogenesis and treatment. Minerva Urol Nefrol (2013) 0.81
Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy. Am J Transplant (2016) 0.81
Genotypic variation and outcomes in kidney transplantation: donor and recipient effects. Kidney Int (2013) 0.78
The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects. Pediatr Nephrol (2013) 0.78
Outcomes of Renal Transplantation in HIV-1 Associated Nephropathy. PLoS One (2015) 0.77
Kidney disease: new technologies translate mechanisms to cure. J Clin Invest (2014) 0.77
Genome-wide association studies in pediatric chronic kidney disease. Pediatr Nephrol (2015) 0.77
APOL1 and nephropathy progression in populations of African ancestry. Semin Nephrol (2013) 0.77
Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era. Semin Nephrol (2015) 0.77
The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease. Clin Exp Nephrol (2014) 0.76
Social Determinants of Racial Disparities in CKD. J Am Soc Nephrol (2016) 0.76
Actualizing the Benefits of Genomic Discovery in Pediatric Nephrology. J Pediatr Genet (2015) 0.75
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Kidney Int (2015) 0.75
Identifying the Intracellular Function of APOL1. J Am Soc Nephrol (2017) 0.75
Infection-Related Focal Segmental Glomerulosclerosis in Children. Biomed Res Int (2016) 0.75
Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review. Int J Prev Med (2014) 0.75
Transplant genetics and genomics. Nat Rev Genet (2017) 0.75
Kidney transplant results in children: progress made, but blacks lag behind. Kidney Int (2015) 0.75
Genes, Exomes, Genomes, Copy Number: What is Their Future in Pediatric Renal Disease. Curr Pediatr Rep (2012) 0.75
APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial. KI Rep (2017) 0.75
Kidney function is associated with an altered protein composition of high-density lipoprotein. Kidney Int (2017) 0.75
Late Reoccurrence of Collapsing FSGS After Transplantation of a Living-Related Kidney Bearing APOL 1 Risk Variants Without Disease Evident in Donor Supports the Second Hit Hypothesis. Transplant Direct (2017) 0.75
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (2011) 4.80
The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant (2011) 3.69
The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol (2010) 3.15
APOL1 localization in normal kidney and nondiabetic kidney disease. J Am Soc Nephrol (2011) 2.61
Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L. J Biol Chem (1997) 2.53
A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int (2010) 2.22
The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics (2002) 2.20
The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum Mol Genet (2011) 1.71
Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol (2011) 1.70
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol (2011) 1.67
Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population. Am J Nephrol (2011) 1.52
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
Role of beta3 integrin in acute renal allograft rejection in humans. Clin J Am Soc Nephrol (2007) 0.86
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (1986) 11.35
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39
Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J (1986) 6.08
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
Manslaughter convictions for making mistakes. BMJ (1991) 5.56
Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93
The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J (1986) 4.47
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Government to introduce safer administration of cancer drugs after fatal error. BMJ (2001) 3.79
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med (1998) 3.76
Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1998) 3.72
Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell (2000) 3.47
Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science (1995) 3.46
Persistent vegetative state and the right to die: the United States and Britain. BMJ (1991) 3.38
Consultant suspended for not getting consent for cardiac procedure. BMJ (1998) 3.33
Doctor demands payment for helping airline passenger. BMJ (1998) 3.26
Bristol inquiry condemns hospital's "club culture". BMJ (2001) 3.25
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet (1995) 3.18
Spreading HIV is not an offence. BMJ (1992) 3.17
The Gillick judgment. Contraceptives and the under 16s: House of Lords ruling. Br Med J (Clin Res Ed) (1985) 3.10
IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br J Dermatol (1984) 2.95
Doctor who refused HIV test is struck off register. BMJ (1997) 2.94
High Court throws out "suicide aid" case. BMJ (2001) 2.92
Rates, timing and causes of neonatal deaths in rural India: implications for neonatal health programmes. Bull World Health Organ (2006) 2.90
Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature (1989) 2.82
Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77
Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems. J Hosp Infect (2012) 2.71
Wisheart begins to give evidence at GMC. BMJ (1998) 2.69
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology (2000) 2.67
Gynaecologist cleared in hysterectomy case. BMJ (2000) 2.62
Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol (2000) 2.57
New agency set up to identify incompetent doctors. BMJ (2001) 2.57
The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol (1986) 2.48
2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med (1998) 2.48
Prevalence by Self-report questionnaire and recognition by nonpsychiatric physicians. Arch Gen Psychiatry (1980) 2.47
Natural killer cells: definition of a cell type rather than a function. J Immunol (1986) 2.46
Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J Exp Med (1989) 2.45
Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitus. J Pediatr (1993) 2.44
British GP cleared of murder charge. BMJ (1999) 2.42
[Not Available]. J Minim Access Surg (2008) 2.41
Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A (1998) 2.32
Perforin: more than just an effector molecule. Immunol Today (2000) 2.30
Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med (2001) 2.30
Pharmacognostic study and anti-inflammatory activity of Callistemon lanceolatus leaf. Asian Pac J Trop Biomed (2011) 2.30
The N-terminal DNA-binding 'zinc finger' of the oestrogen and glucocorticoid receptors determines target gene specificity. EMBO J (1988) 2.28
Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother (1995) 2.16
Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India. J Perinatol (2006) 2.16
Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J (2000) 2.13
A detailed genetic map for the X chromosome of the malaria vector, Anopheles gambiae. Science (1993) 2.10
Sequence of a cDNA from the mosquito Anopheles gambiae encoding a homologue of human ribosomal protein S7. Nucleic Acids Res (1993) 2.07
Nutritional status of preschool Mexican-American migrant farm children. Am J Dis Child (1971) 2.06
The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res (1989) 2.05
Overhaul of medical negligence litigation announced. BMJ (1996) 2.04
Selective abortions hit the headlines. BMJ (1996) 2.04
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant (2015) 2.03
Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn (1998) 1.99
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem (1998) 1.98
Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med (1987) 1.95
Anvirzel, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs (2000) 1.95
HIV infected haemophiliacs settle. BMJ (1991) 1.94
Smokers in Britain get legal aid. BMJ (1995) 1.92
Selection with gene-cytoplasm interactions. I. Maintenance of cytoplasm polymorphisms. Genetics (1984) 1.88
Murine natural killer cells and marrow graft rejection. Annu Rev Immunol (1992) 1.87
Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol (1993) 1.87
Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene (1997) 1.85
The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity (1996) 1.84
The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation. Proc Natl Acad Sci U S A (1988) 1.84
Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med (2001) 1.83
Vector control in leishmaniasis. Indian J Med Res (2006) 1.81
Assault on a GP. Br Med J (Clin Res Ed) (1987) 1.80
Missed neuroleptic malignant syndrome. BMJ (1992) 1.79
Doctors with AIDS and the "News of the World". Br Med J (Clin Res Ed) (1987) 1.78
Consent and the mentally handicapped. Br Med J (Clin Res Ed) (1987) 1.77
Gynaecologist acquitted in hysterectomy case. BMJ (1996) 1.69
Vitamin B12 deficiency presenting as pyrexia. J Assoc Physicians India (2011) 1.68
Tighter control on GPs to follow doctor's murder convictions. BMJ (2000) 1.66
Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population. Gut (2011) 1.65
Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med (1998) 1.65
A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. Int J Parasitol (1992) 1.65
Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. Mol Microbiol (1999) 1.61
Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant (2012) 1.61
A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol (1993) 1.61
Paediatricians' knowledge of cardiac arrest guidelines. Arch Dis Child (1996) 1.61
Medical litigation faces British revolution. BMJ (1996) 1.61
Withdrawal of food supplement judged as misconduct. BMJ (1999) 1.60
Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem (1996) 1.59
IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci (1983) 1.59
Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J Immunol (1993) 1.57
Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med (1987) 1.56
Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J Immunol (1983) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol (1988) 1.55
Bromocriptine: a novel approach to the treatment of type 2 diabetes. Diabetes Care (2000) 1.55
Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol (2002) 1.54
Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes. Proc Natl Acad Sci U S A (1986) 1.54
Validation of causes of infant death in the community by verbal autopsy. Indian J Pediatr (1988) 1.54
Thousands of patients may be being detained illegally. BMJ (1998) 1.54
Maternal mortality inquiry in a rural community of north India. Int J Gynaecol Obstet (1989) 1.53
Microscopic evaluation and physiochemical analysis of Dillenia indica leaf. Asian Pac J Trop Biomed (2011) 1.51